Ahead of Oxford Global’s R&D Series Drug Discovery Summit on 26-27 May 2019 in Berlin, Germany, Oxford Global spoke to Torsten Hoffmann of Taros Chemicals about his work in Pharmaceutical R&D and the opportunities and challenges in Drug Discovery…
Home » Home
Drug Discovery
Taros’ international and multidisciplinary team has more than 180 years of pharmaceutical R&D experience. Collectively as a team, we worked on more than 120 biomolecular...
medicinal chemistry
Drug Discovery
Material Science
As a leading Contract Research Organization in Europe, Taros provides valuable contract discovery for synthetic organic chemistry, chemical process development, and pilot plant manufacturing services to meet our clients’ needs at…
synthetic organic chemistry
Custom synthesis
Material Science
We create performance chemicals to enhance new materials, plastics, coatings, dyes & inks, cosmetics, flavors and many more research and industrial applications...
performance chemicals
Material Science
Latest News
Read more
I3-STM dealt with a new, tailor-made immunotherapeutic approach using small antibody mimetics synthesized for the therapy of triple-negative breast cancer (TNBC), which is still insufficiently treated with the classic methods. These drugs consist of components that stimulate the immune system and…
The R&D Series features 3 outstanding programmes bringing together Europe’s most successful pharmaceutical organisations, top biotech companies and internationally renowned academic institutions specialising in therapeutic areas. The event includes over 100 cutting-edge…
Drug Discovery Strategic Summit highlights the advances in current and emerging hot targets and technologies, as well as target validation strategies for the discovery and development from biologics to small molecules. DDSS is custom designed to provide an exceptional platform to unfold…
We are transforming your ideas into products
At Taros we regularly perform complex multi-step or enantioselective syntheses with an emphasis on developing and synthesizing novel building blocks, intermediates and final compounds for several applications. We pride ourselves on a 20 year track record of success in supporting diverse industries with their chemistry and innovation challenges. Our scientists specialize in organic and organometallic synthesis including polymers, from lab to pilot quantities. Taros operates a customer-centric and flexible business model providing our diverse clients with customized innovative chemistry services:
We provide long-term added value to our diverse customers through cutting-edge and innovative chemistry-based technologies
Taros creates holistic and cost-effective solutions of the highest quality and reliability for the global marketplace. We are inspired to provide exceptional added value to our customers’ R&D processes by anticipating hurdles foreseeing cost and lead time reductions. tThereby we facilitate competitive and “early-to-market” advantages. With our state-of-the-art lab facilities and our scientists (of which 65% hold a Ph.D. in Chemistry), we are committed to serve the diverse needs of our customers in drug discovery, custom synthesis and specialty or performance chemicals. More than 13,000 synthesis, research and process chemistry projects have been delivered successfully to our ever-growing global customer base.
